BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27586641)

  • 1. High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study.
    Wang HZ; Cao CN; Luo JW; Yi JL; Huang XD; Zhang SP; Wang K; Qu Y; Xiao JP; Li SY; Gao L; Xu GZ
    Radiat Oncol; 2016 Sep; 11(1):113. PubMed ID: 27586641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parotid area lymph node metastases from preliminarily diagnosed patients with nasopharyngeal carcinoma: report on tumor characteristics and oncologic outcomes.
    Xu Y; Zhang M; Xiao Y; Zong J; Qiu S; Bai P; Dai Y; Zhou L; Chen X; Zheng W; Chen Y; Lin S; Pan J
    Oncotarget; 2016 Apr; 7(15):19654-65. PubMed ID: 26934439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
    Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
    Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
    Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
    Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
    Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.
    Tang LL; Tang XR; Li WF; Chen L; Tian L; Lin AH; Sun Y; Ma J
    Oral Oncol; 2017 Jun; 69():68-73. PubMed ID: 28559023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
    Ou X; Miao Y; Wang X; Ding J; He X; Hu C
    Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
    Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
    Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
    Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
    Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
    Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis of nasopharyngeal carcinoma to parotid lymph nodes: a retrospective study.
    Wang S; Lou J; Zhang S; Guo L; Wang K; Ge M
    World J Surg Oncol; 2015 Jan; 13():1. PubMed ID: 25622525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
    Wu MY; He XY; Hu CS
    PLoS One; 2016; 11(4):e0154501. PubMed ID: 27119991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
    Li M; Huang XG; Yang ZN; Lu JY; Zhan YZ; Xie WJ; Zhou DJ; Wang L; Zhu DX; Lin ZX
    Br J Radiol; 2016 Sep; 89(1065):20150621. PubMed ID: 27376590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.
    Chen J; Ou D; He X; Hu C
    Int J Clin Oncol; 2014 Dec; 19(6):998-1004. PubMed ID: 24337503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.
    Wang L; Guo Y; Xu J; Chen Z; Jiang X; Zhang L; Huang S; He X; Zhang Y
    Ann Otol Rhinol Laryngol; 2017 Dec; 126(12):789-797. PubMed ID: 29025277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant value of
    Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
    Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
    Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    Zhang Y; Li WF; Chen L; Mao YP; Guo R; Zhang F; Peng H; Liu LZ; Li L; Liu Q; Ma J
    Sci Rep; 2015 Sep; 5():13919. PubMed ID: 26345410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A split-parotid delineation approach for dose optimization in volumetric modulated arc therapy for nasopharyngeal carcinoma patients with parapharyngeal space invasion and level IIa cervical lymph node involvements.
    Xiao W; Lin Z; Zhang W; Li M; Wu VW
    Br J Radiol; 2016; 89(1060):20150635. PubMed ID: 26838951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.